4.6 Article

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment

Related references

Note: Only part of the references are listed.
Review Medical Laboratory Technology

Circulating Tumor Cells: Liquid Biopsy of Cancer

Catherine Alix-Panabieres et al.

CLINICAL CHEMISTRY (2013)

Article Medicine, General & Internal

Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer

Alice T. Shaw et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Editorial Material Oncology

Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer

Sumithra J. Mandrekar et al.

JOURNAL OF THORACIC ONCOLOGY (2010)

Review Biochemical Research Methods

Circulating tumour cells in clinical practice: Methods of detection and possible characterization

Marianna Alunni-Fabbroni et al.

METHODS (2010)

Review Biochemistry & Molecular Biology

Epithelial-Mesenchymal Transitions in Development and Disease

Jean Paul Thiery et al.

Article Oncology

Cancer statistics, 2008

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2008)

Article Medicine, General & Internal

Erlotinib in previously treated non-small-cell lung cancer

FA Shepherd et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

M Cristofanilli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Pathology

Frequent EpCam protein expression in human carcinomas

PT Went et al.

HUMAN PATHOLOGY (2004)